Concepedia

Yutang Huang

YH

7

Publications

289

Citations

7

H-Index

2018

Active since

Affiliations

Chongqing Medical University(Current)

Central South University

PharmacoGenetics (China)

Changsha Medical University

Chongqing Emergency Medical Center

Yutang Huang is an author at Chongqing Medical University specializing in tumor biology, cell biology, and cancer biology.

Top concepts

MedicineCell BiologyTumor BiologyCancer BiologyPathologyLung CancerCancer ResearchRadiation OncologyOncologyCell Signaling

Publications per year

2018–2024

7

Publications

7

ABCC10 Plays a Significant Role in the Transport of Gefitinib and Contributes to Acquired Resistance to Gefitinib in NSCLC

Hongbo Zhao, Yutang Huang, Jingjing Shi et al. · Frontiers in Pharmacology · 2018 · 79 citations · Full text

CircMYBL1 suppressed acquired resistance to osimertinib in non-small-cell lung cancer

Yaji Li, Nan Wang, Yutang Huang et al. · Cancer Genetics · 2024 · 43 citations

Tumor Biology, Non-small-cell Lung Cancer, Medicine +8

circSETD3 Contributes to Acquired Resistance to Gefitinib in Non-Small-Cell Lung Cancer by Targeting the miR-520h/ABCG2 Pathway

Yutang Huang, Yi Dai, Chunjie Wen et al. · Molecular Therapy — Nucleic Acids · 2020 · 41 citations · Full text

CircSETD3 mediates acquired resistance to gefitinib in non-small lung cancer cells by FXR1/ECT2 pathway

Chunjie Wen, Yaji Li, Yutang Huang et al. · The International Journal of Biochemistry & Cell Biology · 2022 · 36 citations

Medicine, Fxr1/ect2 Pathway, Circsetd3 Mediates +7

Lnc-TMEM132D-AS1 as a potential therapeutic target for acquired resistance to osimertinib in non-small-cell lung cancer

Nan Wang, Qilin Zhao, Yutang Huang et al. · Molecular Omics · 2022 · 33 citations

Rows per page

1–5 of 7